MassBio Annual Meeting & Vendor Expo

Tuesday, March 30 – Wednesday, March 31 2010


Don't miss a chance to network, communicate and collaborate!

These companies will be represented at the MassBio Annual Meeting:


Abbott Bioresearch Center, Inc.
Accounting Management Solutions, Inc.
Adnexus, a Bristol-Myers Squibb R&D Company
Agrivida, Inc.
Alexandria Real Estate Equities, Inc.
Allostera Pharma Inc.
Alnylam Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. 
AMPAC Fine Chemicals (AFC)
Aptuit Consulting, Inc.
Arisaph Pharmaceuticals, Inc.
Ascent Therapeutics, Inc.
Ash Stevens, Inc.
Averion International Corp.
Avila Therapeutics, Inc
Baxter Healthcare
Beth Israel Deaconess Medical Center
Bilcare, Inc.
Bingham McCutchen LLP
BioAssets Development Corp.
Biogen Idec
BioVolutions Inc.
Blue Stream Laboratories
Bostonian Solutions
Brainloop, Inc.
British Consulate-General
Broad Institute of MIT & Harvard
Cambridge Biomedical Inc.
Canadian Consulate General
Catalent Pharma Solutions
Ceiba Solutions, Inc.
Cell Signaling Technology
Celldex Therapeutics, Inc.
Children's Hospital Boston
Clinquest, Inc.
Columbia Construction
CombinatoRx, Inc.
Constellation Pharmaceuticals Inc.
Covance Inc.
Cubist Pharmaceuticals, Inc.
Data Decision Group
Deloitte Recap LLC
Diagnostics for All, Inc.
Dicerna Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc.
Dyax Corp.
Edwards Angell Palmer & Dodge LLP
EMD Serono, Inc.
Ensemble Discovery Corporation
EnVivo Pharmaceuticals, Inc.
EpiZyme, Inc.
Eutropics Pharmaceuticals
Excelimmune, Inc.
Fast Forward, LLC
Flagship Ventures
Foley & Lardner LLP
Foley Hoag LLP
Galenea Corp.
Genetix Pharmaceuticals, Inc.
Genzyme Corporation
GGA Software Services
Gilbane Building Company
Goodwin Procter LLP
Gregory Fryer Associates
Halloran Consulting Group, Inc.
Harvard Clinical Research Institute (HCRI)
Harvard Stem Cell Institute
Harvard University
Hepregen Corporation
Horizon Technology
Hydra Biosciences, Inc.
IDA Ireland
Immuneering Corporation
Korn/Ferry International
L.E.K. Consulting LLC
Massachusetts Biomedical Initiatives (MBI)
Massachusetts General Hospital
Massachusetts Institute of Technology
Massachusetts Life Sciences Center
MBL International
Merck & Co., Inc.
Merck Research Laboratories
Merrimack College
Merrimack Pharmaceuticals, Inc.
Millennium: The Takeda Oncology Company
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Molecular Biometrics, Inc.
MS&L Worldwide
New England Biolabs
Nixon Peabody LLP
Northeastern University
Nutter McClennen & Fish LLP
Ontario Ministry of International Trade and Investment 
OPK Biotech
ORBee Consulting
Organogenesis, Inc.
Palatucci Executive Search, LLC.
PAREXEL International Corp.
Partners HealthCare System, Inc.
PCI Synthesis
PearTree Pharmaceuticals, Inc.
Peptimmune, Inc.
Pervasis Therapeutics, Inc.
Pfizer, Inc. Research Technology Center
Phase Forward, Inc.
Pierce Atwood LLP
Pioneer Valley Life Sciences Institute
PricewaterhouseCoopers, LLP
Quanticate Inc.
Repligen Corporation
RXi Pharmaceuticals Corporation
Sanofi Aventis Pharmaceuticals
Satori Pharmaceuticals Incorporated
Sepracor, Inc.
SGS Life Science Services
Shire Pharmaceuticals
Silicon Valley Bank
SourceOne Inc.
Strategic Science & Technologies
Sturgeon Capital Management
Sunstein Kann Murphy & Timbers LLP
Synomics Pharmaceutical Services
Talaris Advisors L.L.C.
Tempero Pharmaceuticals 
Tetragenetics, Inc.
TGA Sciences, Inc.
The Jackson Laboratory
The Pink Sheet DAILY
The Richmond Group, Inc.
Thermo Fisher Scientific
Thomson Reuters Corporate Advisory Services 
TransForm Pharmaceuticals, Inc.
Trio Clinical Research
UK Trade & Investment
University of Massachusetts
Velesco Pharmaceutical Service
Veolia ES Technical Solutions
Vertex Pharmaceuticals Incorporated
Voisin Consulting, Inc.
Wolfe Laboratories, Inc.
Worcester Polytechnic Institute
World Courier
Xtal Biostructures Inc.
ZIOPHARM Oncology, Inc.

Share MassBio